New cancer diagnostics centre passes planning milestone

Rutherford Health Plc has announced that its subsidiary, Rutherford Diagnostics, has received conditional planning permission to construct a new diagnostics facility in Taunton, Somerset.

Rutherford Diagnostics has entered into a partnership with Somerset NHS Foundation Trust to provide diagnostic services, which Rutherford Diagnostics will deliver from the new state-of-the-art facility in Taunton. The centre, located at the disused Zenith Fire Control Centre in Taunton, is expected to become operational in late 2021.

Rutherford Health hopes to construct five diagnostics centres across the UK as part of an investment agreement with Equitix Limited, a leading investor, developer and long-term fund manager of core infrastructure assets in the UK and Europe.

The centre in Taunton will be the first such facility for Rutherford Diagnostics and will offer Computed Tomography, Magnetic Resonance Imaging, Ultrasound, X-Ray and other relevant diagnostic services. In addition to providing services to NHS patients via the initial five-year contract with Somerset NHS Foundation Trust, the centre will be available to private medical insurance and self-pay patients in the South West.

Steven Powell, chief diagnostics officer at Rutherford Diagnostics, stated: “We are absolutely delighted to have secured a site to construct a state-of-the-art facility which will offer the people of Somerset access to the latest and most advanced diagnostics equipment for a plethora of diseases. Historically the UK’s investment in diagnostics has lagged behind that of its Western European neighbours, particularly cancer and we hope that this facility will usher in a new era of early and fast diagnosis for patients.

“The Covid-19 pandemic has highlighted the pivotal importance of testing and early diagnosis for better patient outcomes and it is only by boosting capacity through facilities such as this we can ensure that we do not end up with vast backlogs in the event of a health crisis.”

David Shannon, Director of Strategy and Improvement for Somerset NHS Foundation Trust, said: “We are very pleased that a site has been conditionally secured for the construction of the Rutherford Diagnostics centre. We entered into our partnership with Rutherford Diagnostics in order to provide diagnostic services and deliver real improvements to patients in Somerset, with Rutherford Diagnostics providing these services from the specialist centre on the outskirts of Taunton. We believe that this partnership will help us to keep pace with the growing demand for diagnostic tests, exacerbated by the COVID-19 pandemic, and are delighted that Rutherford Diagnostics has received conditional planning permission for its new diagnostics facility in Taunton.”

Rutherford announces diagnostics partnership with Somerset NHS Foundation Trust

Rutherford Health has announced that it has entered into a contract with Somerset NHS Foundation Trust to provide diagnostic services via a new state-of-the-art diagnostics facility. The centre will provide a wide range of diagnostic services and will help expedite the delivery of test results.

The agreement with the Trust has been reached with Rutherford Health’s diagnostics subsidiary, Rutherford Diagnostics, and will last for five years with an option to extend to 10 years. The centre is expected to be built and operational by the second half of 2021.

The diagnostic services will include Computed Tomography, Magnetic Resonance Imaging, Ultrasound, X-Ray and other relevant diagnostic services, which will be facilitated by Rutherford Health’s long-term technology partner Philips.

In addition, to providing services to NHS patients, the centre will be available to private medical insurance and self-pay patients in the South West.

The diagnostics centre will be the first of up to five such centres to be built under a Development Framework Agreement between Rutherford Health and Equitix, a leading investor, developer and long-term fund manager of core infrastructure and energy-efficiency assets in the UK and Europe. The centre will be at a site, to be confirmed, in the Taunton area.

Mike Moran, CEO of Rutherford Health, said: “We are delighted to be announcing this partnership with Somerset NHS Foundation Trust. At a time when Covid-19 has impacted healthcare services across the board, this agreement demonstrates the tremendous potential of collaboration between the independent and public sectors. Our state-of-the-art facility will be built at no capital cost to the NHS but it will primarily be NHS patients who benefit.

“This partnership is also very timely. The need for faster, more efficient diagnostics services was identified as a priority in the NHS 10-year plan and that was prior to the Covid-19 pandemic and the knock-on effect it is going to have on services for some time to come. We hope that this partnership will act as a catalyst to transform diagnostic services in Britain.”

David Shannon, Director of Strategy and Improvement for Somerset NHS Foundation Trust, said: “We are delighted to enter into this contract with Rutherford Diagnostics to provide diagnostic services to the population of Somerset. This contract will support us to deliver real improvements to our patients. We want to ensure that we have access to timely, state-of-the-art diagnostics and to provide the best possible experience for our patients. The COVID-19 pandemic has meant our access to diagnostic capacity has been and will continue to be compromised, making this development even more important.”

Dr Steven Powell, chief diagnostics officer at Rutherford Diagnostics, said: “The Rutherford Diagnostics centre provides state of the art MRI, CT, Ultrasound and plain film capability from our long-term technology partner Philips and aims to deliver efficiencies and innovative services for the people of Somerset. Our partnership will deliver better patient experience and health outcomes for the local population.”

Rutherford strikes deal to create new UK diagnositc facilities

Rutherford Health plc is delighted to announce that it has reached agreement to create a network of new diagnostic facilities in the UK. Rutherford has entered into a £55m development framework agreement with Equitix Limited a leading investor, developer and long-term fund manager of core infrastructure assets in the UK and Europe.

Under the terms of the agreement, Rutherford and Equitix will establish up to five new diagnostic facilities in the UK, to provide diagnostic services to the NHS and to private patients. Each centre will provide a variety of diagnostics services including Positron Emission Tomography–Computed Tomography, Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Endoscopy, X-Ray and other relevant diagnostic services.

The framework agreement covers the development of the first five Rutherford diagnostics centres with an estimated value of approximately £55 million. Under the terms of the DFA, Equitix will have a right of first refusal in respect of the development and funding of a further five centres beyond the initial five.

Rutherford has already reached agreement with an NHS Trust in England to create the first facility and a further announcement will be released once an SPV has been created under the agreement with Equitix.

The diagnostic centres will be operated by Rutherford Infrastructures Limited and Rutherford Diagnostics Limited will provide diagnostic services.

Equitix is a leading investor, developer and long-term fund manager of core infrastructure and energy-efficiency assets in the UK. Equitix has over £6bn of assets under management. It has invested in healthcare assets since its inception in 2007 and healthcare is now its largest sector for investment, representing over 39% of its total portfolio. Further information can be found at https://equitix.co.uk/.

Mike Moran, Rutherford’s CEO, commented: “We are delighted to have signed this agreement with Equitix. The demand for diagnostic capability in the NHS, and private sector, has increased significantly over the last five years with demand outstripping supply year on year. The agreement with Equitix will enable Rutherford Diagnostics to meet the rising demand for diagnostic clinical services”.

Geoff Jackson, Chief Executive Officer of Equitix, commented: “We are very pleased to work in partnership with Rutherford to provide the financing for these diagnostic centres. We have demonstrated a strong track record in our ownership and management of healthcare assets, particularly in this time of crisis where we have been working to support NHS staff on the front-line and, as such, we are pleased to be further consolidating our capabilities and adding these assets to our institutional investment portfolios.”